Clockwise from top left: Safebeat Rx’s AFib remote monitoring, LiveMetric wearable blood pressure monitor, Respirix’s Cardiospire noninvasive hemodynamic monitor, CardiaCare wearable noninvasive nerve stimulator {images courtesy of the companies]
In the fast-evolving field of cardiology, medical device startups are emerging as key players, bringing new ideas and technologies to the table.
With a focus on agility and creativity, cardiology medical device startups are challenging established players in the industry and disrupting traditional models of healthcare delivery. From wearables and remote monitoring devices to AI-powered diagnostics and minimally invasive procedures, these startups are redefining what is possible in the world of cardiology.
Investors are taking notice of the potential of these startups, pouring millions of dollars into their ventures. As a result, many of these companies are experiencing rapid growth and expanding their reach across the globe.
As the cardiology landscape continues to evolve, medical device startups are likely to play an increasingly important role in shaping the future of the industry. These seven companies are developing innovative solutions that aim to improve the diagnosis, treatment and management of cardiovascular diseases.
CardiaCare: Closed-loop wearable for noninvasive treatment of cardiac clinical symptoms
Rehovot, Israel Founded: 2015
CardiaCare is a clinical-stage digital therapeutic company that is developing a closed-loop wearable device for the noninvasive treatment of cardiac and other central nervous system-related clinical symptoms. The nerve stimulation system has continuous monitoring and AI-based alert capabilities to enable complete remote patient management and personalized treatment.
The company currently has a functional prototype and has successfully completed a first-in-man study. CardiaCare is also a 2022 MedTech Innovator cohort company.
LiveMetric is the only FDA-cleared, calibration-free, cuff-free, continuous blood pressure wearable that provides thousands of measurements per month. The measurements are digitally transmitted to a provider to help make important care and treatment decisions. The company’s LiveOne device uses algorithms that analyze a person’s radial artery pressure to produce diastolic, systolic and pulse rates for people ages 27 and up.
Respirix’s Cardiospire technology is a new approach to noninvasive hemodynamic monitoring using airway pressure for continuous, high-fidelity modeling of stroke volume and pulmonary artery pressures. Cardiospire is placed inline using a capnography adapter and provides accurate AI modeling of core hemodynamic parameters. It displaces the catheterization risk and removes the guesswork from hemodynamic management to improve patient outcomes.
SafeBeat has developed technology that expands access to remote patient monitoring, continuous telemetry and event monitoring. It also has software-enabled remote therapeutic monitoring and cardiac implantable electronic device monitoring powered by automated artificial intelligence-based software. According to the company, the system has ECG interpretation and treatment management coupled with AI to increase physician efficiency with automated insights.
